National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.
The metrics are intended to provide an objective and constant way of evaluating the value of the repositories as well as the datasets they contain.
The healthcare provider organizations are tasked with managing patient enrollment in the Precision Medicine Initiative.
NIH Director Francis Collins describes changes to improve clinical trials in JAMA this week.
The institute has also been awarded additional funding from the National Institutes of Health for its increased participation in the initiative.
The funding, which is part of the NIH’s Common Fund, supports high-impact biomedical research that produces new insights into genomics and human disease.
Frameshift plans to commercialize two applications: one for data quality control and a second for identifying mutations in rare and Mendelian disorders.
Mutations in the PIEZO2 gene in two individuals with undiagnosed muscle, sensory, and skeletal conditions suggest the protein product plays a role in touch perception.
The agency is seeking grant applications for projects using genomics to study HIV/AIDS drug responses and comorbidities.
NHGRI researchers showed that they were able to extract more useful pharmacogenetic information from exome data than from current chip data.
In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.
Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.
According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.